{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:51:17Z","timestamp":1786989077780,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.exppara.2023.108460","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T02:25:33Z","timestamp":1673576733000},"page":"108460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice"],"prefix":"10.1016","volume":"246","author":[{"given":"Wesam Moustafa","family":"Abdelhamid Elgendy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf A.","family":"Haggag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud A.","family":"El-Nouby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy I.","family":"El-Kowrany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirria M.","family":"El Marhoumy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2023.108460_bib1","article-title":"Immunological effects of a single dose of PLGA nanoparticles encapsulated peptide in broilers in comparison to traditional vaccines against infectious bursal disease","volume":"39","author":"Al-Rubaee","year":"2019","journal-title":"Agric. Sci. Digest"},{"key":"10.1016\/j.exppara.2023.108460_bib2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1021\/acsinfecdis.9b00263","article-title":"Repositioning of guanabenz in conjugation with gold and silver nanoparticles against pathogenic amoebae Acanthamoeba castellanii and Naegleria fowleri","volume":"5","author":"Anwar","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.exppara.2023.108460_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015434","article-title":"Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)","volume":"7","author":"Bella","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.exppara.2023.108460_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2353\/ajpath.2008.080129","article-title":"CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system","volume":"173","author":"Benevides","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exppara.2023.108460_bib5","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1128\/AAC.01683-15","article-title":"Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis","volume":"59","author":"Benmerzouga","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2023.108460_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3390\/pharmaceutics12121165","article-title":"Doxorubicin-loaded PLGA nanoparticles for cancer therapy: molecular weight effect of PLGA in doxorubicin release for controlling immunogenic cell death","volume":"12","author":"Choi","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exppara.2023.108460_bib7","first-page":"1","article-title":"Latent toxoplasmosis and human","volume":"7","author":"Dalimi","year":"2012","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.exppara.2023.108460_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exppara.2015.06.005","article-title":"Could miltefosine be used as a therapy for toxoplasmosis?","volume":"157","author":"Eissa","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2023.108460_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.actatropica.2019.04.013","article-title":"Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis","volume":"195","author":"El-Kowrany","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2023.108460_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.20546\/ijcmas.2019.812.072","article-title":"An Experimental study on the effect of pyrimethamine-loaded niosomes in the treatment of acute toxoplasmosis","volume":"8","author":"El-Mansory","year":"2019","journal-title":"Int . J. Curr. Microbio. Appl. Sci."},{"key":"10.1016\/j.exppara.2023.108460_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.actatropica.2014.09.020","article-title":"Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with acystogenic ME49 strain of Toxoplasma gondii","volume":"141","author":"El-Zawawy","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2023.108460_bib12","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00436-016-5041-2","article-title":"Effects of Thymus vulgaris ethanolic extract on chronic toxoplasmosis in a mouse model","volume":"115","author":"Eraky","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2023.108460_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4172\/2157-7439.1000184","article-title":"Use of nanotechnology to develop multi-drug inhibitors for cancer therapy","volume":"4","author":"Gowda","year":"2013","journal-title":"J. Nanomed. Nanotechnol."},{"key":"10.1016\/j.exppara.2023.108460_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpharm.2015.12.063","article-title":"Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG","volume":"499","author":"Haggag","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.exppara.2023.108460_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/bdd.2255","article-title":"Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity","volume":"42","author":"Haggag","year":"2021","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.exppara.2023.108460_bib33","doi-asserted-by":"crossref","first-page":"120532","DOI":"10.1016\/j.ijpharm.2021.120532","article-title":"Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer","volume":"600","author":"Haggag","year":"2021","journal-title":"Int. J. Pharm"},{"key":"10.1016\/j.exppara.2023.108460_bib14","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1128\/IAI.68.6.3426-3430.2000","article-title":"Investigation into the mechanism of gamma interferon-mediated inhibition of Toxoplasma gondii in murine astrocytes","volume":"68","author":"Halonen","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.exppara.2023.108460_bib15","first-page":"138","article-title":"Parasitological and immunological study of the effect of chitosan and chitosan nanoparticles loaded with spiramycin on toxoplasmosis","volume":"10","author":"Hamad","year":"2018","journal-title":"J. Global Pharma Technol."},{"key":"10.1016\/j.exppara.2023.108460_bib16","first-page":"1A","article-title":"A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy","volume":"27","author":"Karnovsky","year":"1965","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exppara.2023.108460_bib17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/09205063.2020.1743946","article-title":"Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin","volume":"31","author":"Khaledi","year":"2020","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.exppara.2023.108460_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00036","article-title":"Treatment of toxoplasmosis: current options and future perspectives","volume":"15","author":"Konstantinovic","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"10.1016\/j.exppara.2023.108460_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.exppara.2023.108460_bib20","first-page":"2207","article-title":"Novel PLGA-based nanoparticles for the oral delivery of insulin","volume":"10","author":"Malathi","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.exppara.2023.108460_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00381-19","article-title":"Guanabenz reverses a key behavioral change caused by latent toxoplasmosis in mice by reducing neuroinflammation","volume":"10","author":"Martynowicz","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.exppara.2023.108460_bib22","first-page":"419","article-title":"The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations","volume":"238","author":"Matuschka","year":"1977","journal-title":"Zentralblatt Bakteriol. Parasitenkd. Infekt. Hyg. Erste Abt. Orig. Reihe A: Med. Mikrobiol. Parasitol."},{"key":"10.1016\/j.exppara.2023.108460_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2008.06.103","article-title":"Guanabenz, an alpha2-selective adrenergic agonist, activates Ca2+-dependent chloride currents in cystic fibrosis human airway epithelial cells","volume":"592","author":"Norez","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exppara.2023.108460_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2013.11.011","article-title":"Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia","volume":"152","author":"Notarangelo","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.exppara.2023.108460_bib24","first-page":"228","article-title":"Nanoparticle: an overview of preparation and characterization","author":"Pal","year":"2011","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.exppara.2023.108460_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00436-013-3715-6","article-title":"Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis","volume":"113","author":"Pissinate","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2023.108460_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21608\/bmfj.2021.144709","article-title":"Assessment of nitazoxanide loaded on silver nanoparticles efficacy on treatment of murine model of chronic toxoplasmosis","volume":"38","author":"Saleh","year":"2021","journal-title":"Benha Med. J."},{"key":"10.1016\/j.exppara.2023.108460_bib27","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/AAC.47.12.3859-3866.2003","article-title":"Triclosan as a systemic antibacterial agent in a mouse model of acute bacterial challenge","volume":"47","author":"Sharma","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2023.108460_bib28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/ijms17050674","article-title":"Guanabenz downregulates inflammatory responses via eIF2\u03b1 dependent and independent signaling","volume":"17","author":"Takigawa","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exppara.2023.108460_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1039\/C5BM00383K","article-title":"Strategies for transporting nanoparticles across the blood-brain barrier","volume":"4","author":"Zhang","year":"2016","journal-title":"Biomater. Sci."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489423000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489423000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:30:27Z","timestamp":1758004227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489423000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":33,"alternative-id":["S0014489423000012"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2023.108460","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2023.108460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108460"}}